Korro Bio, Inc
Price
FilingsNewest: 8-K, Other eventsOct 5 →Insiders13 insiders bought $20.7M in 10 open-market buys. 6 insiders sold $2.2M, 6 of 11 sales on a 10b5-1 plan.→HoldersLynx1 10.5%Nantahala 9.0%Nea 8.8%→PeersClosest companies: DSGN, TNYA, MGX→
From the filings
Figures
- Revenue
- $2.4Mlast 12 months
- Net income
- −$106.6Mlast 12 months
- Operating cash flow
- −$70.2Mlast 12 months
- Cash and equivalents
- $24.9Mat the last balance sheet
- Shares outstanding
- 14.7M shareson issue